xMD Diagnostics
Annapolis, US · Maryland corporation · 2 known investors
xMD Diagnostics is a diagnostics company developing medical testing technology. The page identifies the leadership team but provides limited detail about the company's specific products.
BiotechHealthtechMedical Devices
Founders & leadership
BS
Benjamin ShapiroCo-Founder, Technical Advisor
AF
Al FleuryExecutive
TP
Ting Pau OeiCEO and Co-Chairman
ME
Michael Emmert-BuckNamed on SEC filing
NM
Nicole Massoll, M.D.Medical Director, Pathologist
Board
SR
Stephen RitterbushCFO and Co-Chairman
Investors · 2
Competitors · 3
by search overlapMDxHealth6 shared keywordsmdxhealth develops molecular diagnostic tests for urologic diseases, with a focus on prostate cancer. Its products—Confirm mdx, GPS mdx, and Exo mdx—help physicians assess cancer risk, address false-negative biopsies, and guide treatment decisions for patients.
Advancedmd4 shared keywordsAdvancedMD provides a cloud-based platform combining electronic health records, practice management, patient engagement, and revenue cycle management with AI-enabled automation for independent healthcare practices. It serves single-provider offices, large group practices, and medical billing service companies across specialties in the US.
Cdxdiagnostics4 shared keywordsCDx Diagnostics offers a diagnostic platform that combines enhanced tissue sampling, AI-assisted analysis, 3D imaging, and genetic testing to detect precancerous cells and dysplasia. The technology is aimed at physicians for early detection and prevention of cancer, including esophageal cancer.
Companies competing with xMD Diagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$675K disclosed across 2 rounds · 2017–2018
▶$500KraisedOct 2018 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedOct 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen R. RitterbushExecutive Officer, Director
- Ting Pau OeiExecutive Officer, Director
- Benjamin ShapiroExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $500K
- First sale
- Oct 2018
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
▶$175KraisedMar 2017 · 1 investors · BiotechnologyRule 506(b)
▶$175KraisedMar 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Al FleuryExecutive Officer
- Michael Emmert-BuckExecutive Officer
- Ting Pau OeiExecutive Officer, Director
- Benjamin ShapiroExecutive Officer, Director
- Stephen RitterbushExecutive Officer, Director
- Offering amount
- $350K
- Amount sold
- $175K
- Proceeds to insiders
- $35K
- First sale
- Jan 2017
- Incorporated
- Limited Liability Company, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2021 | $256K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does xMD Diagnostics do?
- xMD Diagnostics is a diagnostics company developing medical testing technology. The page identifies the leadership team but provides limited detail about the company's specific products.
- Who founded xMD Diagnostics?
- xMD Diagnostics was founded by Benjamin Shapiro.
- Who are xMD Diagnostics's investors?
- xMD Diagnostics's investors include Maryland TEDCO, TEDCO.
- How much funding has xMD Diagnostics raised?
- xMD Diagnostics has disclosed $675K raised across 2 rounds.
- Where is xMD Diagnostics headquartered?
- xMD Diagnostics is headquartered in Annapolis, US.